Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryo Tamura

Showing results (121-130 of 140) with videos related to

Pageof 14
Sort By:
STAR Protocols|March 5, 2021
Establishment of <i>in vitro</i> 3D spheroid cell cultivation from human gynecologic cancer tissuesHaruka Ueda, Yutaro Mori, Kaoru Yamawaki, et al.
Science and Technology of Advanced Materials|December 17, 2024
Theoretical and data-driven approaches to semiconductors and dielectrics: from prediction to experimentFumiyasu Oba, Takayuki Nagai, Ryoji Katsube, et al.
Cancer Science|March 6, 2021
Biological significance of KRAS mutant allele expression in ovarian endometriosisNozomi Yachida, Kosuke Yoshihara, Kazuaki Suda, et al.
Scientific Reports|June 29, 2017
Peptides derived from MARCKS block coagulation complex assembly on phosphatidylserineNoah Kastelowitz, Ryo Tamura, Abimbola Onasoga, et al.
Cell Reports|August 16, 2018
Clonal Expansion and Diversification of Cancer-Associated Mutations in Endometriosis and Normal EndometriumKazuaki Suda, Hirofumi Nakaoka, Kosuke Yoshihara, et al.
Scientific Reports|September 2, 2020
ARID1A protein expression is retained in ovarian endometriosis with ARID1A loss-of-function mutations: implication for the two-hit hypothesisNozomi Yachida, Kosuke Yoshihara, Kazuaki Suda, et al.
Iscience|April 2, 2021
Three-dimensional understanding of the morphological complexity of the human uterine endometriumManako Yamaguchi, Kosuke Yoshihara, Kazuaki Suda, et al.
Current Oncology (Toronto, Ont.)|May 26, 2026
Lenvatinib Combined with New FP Hepatic Arterial Infusion Chemotherapy for Unresectable Hepatocellular Carcinoma: Clinical Efficacy, Vascular Remodeling, and Implications for Immuno-Oncology-Systemic Combination TherapySusumu Maruta, Yohei Koshima, Yuji Debari, et al.
JAMA Network Open|June 16, 2023
Uptake and Outcomes of Neoadjuvant Chemotherapy Among US Patients With Less Common Epithelial Ovarian CarcinomasKoji Matsuo, Shinya Matsuzaki, Michihide Maeda, et al.
Scientific Reports|November 30, 2019
Germline and somatic mutations of homologous recombination-associated genes in Japanese ovarian cancer patientsKentaro Sugino, Ryo Tamura, Hirofumi Nakaoka, et al.
Pageof 14

Showing results (121-130 of 140) with videos related to

Sort By:
Pageof 14
STAR Protocols|March 5, 2021
Establishment of <i>in vitro</i> 3D spheroid cell cultivation from human gynecologic cancer tissuesHaruka Ueda, Yutaro Mori, Kaoru Yamawaki, et al.
Science and Technology of Advanced Materials|December 17, 2024
Theoretical and data-driven approaches to semiconductors and dielectrics: from prediction to experimentFumiyasu Oba, Takayuki Nagai, Ryoji Katsube, et al.
Cancer Science|March 6, 2021
Biological significance of KRAS mutant allele expression in ovarian endometriosisNozomi Yachida, Kosuke Yoshihara, Kazuaki Suda, et al.
Scientific Reports|June 29, 2017
Peptides derived from MARCKS block coagulation complex assembly on phosphatidylserineNoah Kastelowitz, Ryo Tamura, Abimbola Onasoga, et al.
Cell Reports|August 16, 2018
Clonal Expansion and Diversification of Cancer-Associated Mutations in Endometriosis and Normal EndometriumKazuaki Suda, Hirofumi Nakaoka, Kosuke Yoshihara, et al.
Scientific Reports|September 2, 2020
ARID1A protein expression is retained in ovarian endometriosis with ARID1A loss-of-function mutations: implication for the two-hit hypothesisNozomi Yachida, Kosuke Yoshihara, Kazuaki Suda, et al.
Iscience|April 2, 2021
Three-dimensional understanding of the morphological complexity of the human uterine endometriumManako Yamaguchi, Kosuke Yoshihara, Kazuaki Suda, et al.
Current Oncology (Toronto, Ont.)|May 26, 2026
Lenvatinib Combined with New FP Hepatic Arterial Infusion Chemotherapy for Unresectable Hepatocellular Carcinoma: Clinical Efficacy, Vascular Remodeling, and Implications for Immuno-Oncology-Systemic Combination TherapySusumu Maruta, Yohei Koshima, Yuji Debari, et al.
JAMA Network Open|June 16, 2023
Uptake and Outcomes of Neoadjuvant Chemotherapy Among US Patients With Less Common Epithelial Ovarian CarcinomasKoji Matsuo, Shinya Matsuzaki, Michihide Maeda, et al.
Scientific Reports|November 30, 2019
Germline and somatic mutations of homologous recombination-associated genes in Japanese ovarian cancer patientsKentaro Sugino, Ryo Tamura, Hirofumi Nakaoka, et al.
Pageof 14